Redwood Pharma to attend BIO-Europe Nov. 10-12 in Hamburg
Redwood Pharma will be attending BIO-Europe, Europe’s largest life sciences partnering conference, November 10-12 in Hamburg, Germany, to discuss potential partnering, development and other business collaborations for RP101, the Company’s lead product under development.RP101 is a novel, topical treatment for post-menopausal women suffering from chronic, moderate-to-severe dry eye disease (DED), and consists of a low-dose estrogen analog formulated in a proprietary controlled-release drug delivery platform, IntelliGel. The active substance has already been proven safe and efficacious in two